Healthcare -
Biotechnology - NYSE - CH
$ 1.635
-7.1 %
$ 158 M
Market Cap
-0.68
P/E
ADCT - COMMON STOCK REPURCHASED
Common Stock Repurchased ADCT - ADC Therapeutics SA
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR